Dudley Robert Michael's Form 4 filing
Transcode Therapeutics, Inc. (RNAZ) · filed Jun 13, 2023
- Accession no.
- 0001104659-23-070804
- Filed
- Jun 13, 2023
- Trade date
- Jun 9, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $52.4K. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0001104659-23-071204 (Jun 14, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dudley Robert MichaelCIK 0001854161 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2023 | Common Stock | PPurchaseAcquired | +19,000 | $2.76 | +$52,440 | 912,114 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.